Pharmaceutical Contract Sales Outsourcing [CSO] Market (Service: Personal Promotion, Non-personal Promotion, and Others) - North America Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Oct 2022| TMR3200B| Transparency

Report Highlights

North America Pharmaceutical Contract Sales Outsourcing (CSO) Market – Scope of Report

TMR’s report on the pharmaceutical contract sales outsourcing (CSO) market in North America studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the pharmaceutical contract sales outsourcing (CSO) market for the period 2017–2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of pharmaceutical contract sales outsourcing (CSO) market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the pharmaceutical contract sales outsourcing (CSO) market in North America.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the pharmaceutical contract sales outsourcing (CSO) market in North America.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the pharmaceutical contract sales outsourcing (CSO) market in North America. These serve as valuable tools for existing market players as well as for entities interested in participating in the pharmaceutical contract sales outsourcing (CSO) market in North America.

The report delves into the competitive landscape of the pharmaceutical contract sales outsourcing (CSO) market. Key players operating in the pharmaceutical contract sales outsourcing (CSO) market in North America have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the pharmaceutical contract sales outsourcing (CSO) market profiled in this report.

Research Methodology

The research methodology is a combination of exhaustive primary and secondary research to analyze the pharmaceutical contract sales outsourcing (CSO) market.

Secondary Research

Secondary research included a search of company literature, technical writing, patent data, Internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise data, capturing industry participants’ insights, and recognizing business opportunities.

Secondary research sources that we referred to include, but are not limited to:

  • Company websites, presentations, annual reports, white papers, technical papers, product brochures
  • Internal and external proprietary databases and relevant patents
  • National government documents, statistical databases, and market reports
  • News articles, press releases, and webcasts specific to companies operating in the market

Specific Secondary Sources:

  • Industry Sources:
  • Veterinary Council of North America
  • North American Federation of Animal Health
  • Animal Welfare Board of North America
  • Company Information
  • Statista
  • Hoover’s
  • Factiva
  • Bloomberg
  • Mergers & Acquisitions
  • Thomson Mergers & Acquisitions
  • MergerStat
  • Profound

Primary Research

During the course of the research, we conducted in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents the bulk of research efforts, supplemented by extensive secondary research.

We conducted primary interviews with industry participants and commentators to validate data and analysis. A typical research interview fulfills the following functions:

  • Provides first-hand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
  • Helps in validating and strengthening secondary research findings
  • Develops the analysis team’s expertise and market understanding
  • Primary research involves e-mail interactions, telephonic interviews, as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies

Participants who took part in the process include, but are not limited to:

  • Industry participants: Marketing/product managers, market intelligence managers, and regional sales managers
  • Purchasing/sourcing managers, technical personnel, distributors
  • Outside experts: Investment bankers, valuation experts, and research analysts
  • Key opinion leaders specializing in the market with respect to different industry verticals

Primary participants included, but are not limited to:

  • Bayer AG
  • Elanco Products Company
  • Merck & Co., Inc.
  • Ceva Sante Animale
  • Virbac SA

Report Synopsis

Report Metrics Details
Base year considered 2022
Forecast period considered 2022-2031
Growth rate 7.40%
Units considered $ Million
Segments covered By Service, By Personal Promotion, By Promotional Sales Team, By Non-Personal Promotion, By Therapeutic Area, By Region
Industry covered Pharmaceutical
Countries covered North America
Companies studied
  • Ashfield (UDG Healthcare plc),
  • Amplity Health,
  • Granard Pharmaceutical Sales & Marketing,
  • Syneos Health,
  • IQVIA,
  • EVERSANA

Data Triangulation: Information culled from “Secondary & Primary Sources” is cross-checked with “TMR Knowledge Repository”, which is updated every quarter

Market Estimation: Market size estimations involved an in-depth study of product features, technology updates, geographic presence, product demand, sales data (value or volume), historical year-on-year growth, and others. Other approaches were also utilized to derive market size and forecasts. Where no hard data was available, we used modeling techniques in order to produce comprehensive datasets. A rigorous methodology has been adopted, wherein the available hard data are cross-referenced with the following data types to produce estimates:

Demographic Data: Population, inflation rates, and others

Industry Indicators: Production data, R&D investment, technology stage, and infrastructure, sector growth, and facilities

Market Forecasting: Market forecasts for various segments are derived by taking into account drivers, restraints/challenges, opportunities prevailing in the market, and considering advantages/disadvantages of segments/sub-segments over other segments/sub-segments. Business environment, historical sales pattern, unmet needs, competitive intensity, and country-wise consumption data are the other pivotal factors considered to derive market forecasts.

  • Table 1 : North America Pharmaceutical Contract Sales Outsourcing [CSO] Market Value (US$ Mn) Forecast, by Service, 2017-2031
  • Table 2 : North America Pharmaceutical Contract Sales Outsourcing [CSO] Market Value (US$ Mn) Forecast, by Personal Promotion, 2017-2031
  • Table 3 : North America Pharmaceutical Contract Sales Outsourcing [CSO] Market Value (US$ Mn) Forecast, by Promotional Sales Team, 2017-2031
  • Table 4 : North America Pharmaceutical Contract Sales Outsourcing [CSO] Market Value (US$ Mn) Forecast, by Non-Personal Promotion, 2017-2031
  • Table 5 : North America Pharmaceutical Contract Sales Outsourcing [CSO] Market Value (US$ Mn) Forecast, by Therapeutic Area, 2017-2031
  • Table 6 : U.S. Pharmaceutical Contract Sales Outsourcing Market Value (US$ Mn) Forecast, by Service, 2017-2031
  • Table 7 : U.S. Pharmaceutical Contract Sales Outsourcing Market Value (US$ Mn) Forecast, by Personal Promotion, 2017-2031
  • Table 8 : U.S. Pharmaceutical Contract Sales Outsourcing Market Value (US$ Mn) Forecast, by Promotional Sales Team, 2017-2031
  • Table 9 : U.S. Pharmaceutical Contract Sales Outsourcing Market Value (US$ Mn) Forecast, by Non-Personal Promotion, 2017-2031
  • Table 10 : U.S. Pharmaceutical Contract Sales Outsourcing Market Value (US$ Mn) Forecast, by Therapeutic Area, 2017-2031
  • Table 11 : Canada Pharmaceutical Contract Sales Outsourcing Market Value (US$ Mn) Forecast, by Service, 2017-2031
  • Table 12 : Canada Pharmaceutical Contract Sales Outsourcing Market Value (US$ Mn) Forecast, by Personal Promotion, 2017-2031
  • Table 13 : Canada Pharmaceutical Contract Sales Outsourcing Market Value (US$ Mn) Forecast, by Promotional Sales Team, 2017-2031
  • Table 14 : Canada Pharmaceutical Contract Sales Outsourcing Market Value (US$ Mn) Forecast, by Non-personal Promotion, 2017-2031
  • Table 15 : Canada Pharmaceutical Contract Sales Outsourcing Market Value (US$ Mn) Forecast, by Therapeutic Area, 2017-2031
  • Figure 1 : North America Pharmaceutical Contract Sales Outsourcing [CSO] Market Value (US$ Mn) Forecast, 2017–2031
  • Figure 2 : North America Pharmaceutical Contract Sales Outsourcing[CSO] Market, by Service, 2021 and 2031
  • Figure 3 : North America Pharmaceutical Contract Sales Outsourcing [CSO] Market Attractiveness Analysis, by Service, 2022–2031
  • Figure 4 : North America Pharmaceutical Contract Sales Outsourcing [CSO] Market (US$ Mn), by Personal Promotion, 2017–2031
  • Figure 5 : North America Pharmaceutical Contract Sales Outsourcing [CSO] (US$ Mn), by Non-personal Promotion, 2017–2031
  • Figure 6 : North America Pharmaceutical Contract Sales Outsourcing [CSO] Market (US$ Mn), by Others, 2017–2031
  • Figure 7 : North America Pharmaceutical Contract Sales Outsourcing Market, by Therapeutic Area, 2021 and 2031
  • Figure 8 : North America Pharmaceutical Contract Sales Outsourcing [CSO] Market Attractiveness Analysis, by Therapeutic Area, 2022–2031
  • Figure 9 : North America Pharmaceutical Contract Sales Outsourcing [CSO] Market (US$ Mn), by Cardiovascular Disorders, 2017–2031
  • Figure 10 : North America Pharmaceutical Contract Sales Outsourcing [CSO] (US$ Mn), by Oncology, 2017–2031
  • Figure 11 : North America Pharmaceutical Contract Sales Outsourcing [CSO] Market (US$ Mn), by Metabolic Disorders, 2017–2031
  • Figure 12 : North America Pharmaceutical Contract Sales Outsourcing [CSO] Market (US$ Mn), by Neurology, 2017–2031
  • Figure 13 : North America Pharmaceutical Contract Sales Outsourcing [CSO] Market (US$ Mn), by Orthopedic Diseases, 2017–2031
  • Figure 14 : North America Pharmaceutical Contract Sales Outsourcing [CSO] Market (US$ Mn), by Infectious Diseases, 2017–2031
  • Figure 15 : North America Pharmaceutical Contract Sales Outsourcing [CSO] Market (US$ Mn), by Others, 2017–2031
  • Figure 16 : U.S. Pharmaceutical Contract Sales Outsourcing Market Value (US$ Mn) Forecast, 2017–2031
  • Figure 17 : U.S. Pharmaceutical Contract Sales Outsourcing Market, by Service, 2021 and 2031
  • Figure 18 : U.S. Pharmaceutical Contract Sales Outsourcing Market Attractiveness Analysis, by Service, 2022–2031
  • Figure 19 : U.S. Pharmaceutical Contract Sales Outsourcing Market (US$ Mn), by Personal Promotion, 2017–2031
  • Figure 20 : U.S. Pharmaceutical Contract Sales Outsourcing Market (US$ Mn), by Non-personal Promotion, 2017–2031
  • Figure 21 : U.S. Pharmaceutical Contract Sales Outsourcing Market (US$ Mn), by Others, 2017–2031
  • Figure 22 : U.S. Pharmaceutical Contract Sales Outsourcing Market, by Therapeutic Area, 2021 and 2031
  • Figure 23 : U.S. Pharmaceutical Contract Sales Outsourcing Market Attractiveness Analysis, by Therapeutic Area, 2022–2031
  • Figure 24 : U.S. Pharmaceutical Contract Sales Outsourcing Market (US$ Mn), by Cardiovascular Disorders, 2017–2031
  • Figure 25 : U.S. Pharmaceutical Contract Sales Outsourcing Market (US$ Mn), by Oncology, 2017–2031
  • Figure 26 : U.S. Pharmaceutical Contract Sales Outsourcing Market (US$ Mn), by Metabolic Disorders, 2017–2031
  • Figure 27 : U.S. Pharmaceutical Contract Sales Outsourcing Market (US$ Mn), by Neurology, 2017–2031
  • Figure 28 : U.S. Pharmaceutical Contract Sales Outsourcing Market (US$ Mn), by Orthopedic Diseases, 2017–2031
  • Figure 29 : U.S. Pharmaceutical Contract Sales Outsourcing Market (US$ Mn), by Infectious Diseases, 2017–2031
  • Figure 30 : U.S. Pharmaceutical Contract Sales Outsourcing Market (US$ Mn), by Others, 2017–2031
  • Figure 31 : Canada Pharmaceutical Contract Sales Outsourcing Market Value (US$ Mn) Forecast, 2017–2031
  • Figure 32 : Canada Pharmaceutical Contract Sales Outsourcing Market, by Service, 2021 and 2031
  • Figure 33 : Canada Pharmaceutical Contract Sales Outsourcing Market Attractiveness Analysis, by Service, 2022–2031
  • Figure 34 : Canada Pharmaceutical Contract Sales Outsourcing Market (US$ Mn), by Personal Promotion, 2017–2031
  • Figure 35 : Canada Pharmaceutical Contract Sales Outsourcing Market (US$ Mn), by Non-personal Promotion, 2017–2031
  • Figure 36 : Canada Pharmaceutical Contract Sales Outsourcing Market (US$ Mn), by Others, 2017–2031
  • Figure 37 : Canada Pharmaceutical Contract Sales Outsourcing Market, by Therapeutic Area, 2021 and 2031
  • Figure 38 : Canada Pharmaceutical Contract Sales Outsourcing Market Attractiveness Analysis, by Therapeutic Area, 2022–2031
  • Figure 39 : Canada Pharmaceutical Contract Sales Outsourcing Market (US$ Mn), by Cardiovascular Disorders, 2017–2031

Leaders in analytics, research and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a prominent provider of a cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who had a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence.

Similar Reports from Transparency

Pharmaceutical Contract Sales Outsourcing (CSO) Market (Therapeutic Area: Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others) - Europe Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

  • Date - Jul 2022
  • Code - TMR3200A

Europe Pharmaceutical Contract Sales Outsourcing (CSO) Market – Scope of Report

TMR’s report on the pharmaceutical contract sales outsourcing (CSO) market in Europe studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the pharmaceutical ...

Transparency
Price: $5795

Become a Member

Already a member? Login here.

Have a Question? Ask Us.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
Custom Research

Need a custom data table, graph or complete report? Tell us more.